Drug profile · INN
diphenylpyraline hydrochloride
HISPRIL
diphenylpyraline hydrochloride (HISPRIL) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — diphenylpyraline hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 2
- Programs
- 0
- Data quality
- 0.84
Quick answer
diphenylpyraline hydrochloride (HISPRIL) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is diphenylpyraline hydrochloride?
diphenylpyraline hydrochloride (HISPRIL) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for diphenylpyraline hydrochloride?
HISPRIL is a marketed brand name for diphenylpyraline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diphenylpyraline hydrochloride?
diphenylpyraline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.